Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
In hepatitis B patients treated with either adefovir or telbivudine, maximal early hbv suppression at 24 weeks predicts optimal one-year efficacy Proceeding/Conference:Journal of Hepatology | 2007 |